Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...

The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving ...

UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...

The US Medicare agency dropped its appeal of a lawsuit brought by UnitedHealth Group Inc. challenging the program’s ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...